Featured Research

from universities, journals, and other organizations

H1N1 Influenza Pandemic Modeling For Public Health Action

Date:
July 21, 2009
Source:
Canadian Medical Association Journal
Summary:
Mathematical modeling can help inform public health policy in outbreaks such as the H1N1 pandemic, write members of the Pandemic Influenza Outbreak Research Modeling Team in Canada. These models are useful tools for simulating plausible scenarios, developing control strategies and identifying important areas for immediate research.

Mathematical modelling can help inform public health policy in outbreaks such as the H1N1 pandemic, write members of the Pandemic Influenza Outbreak Research Modelling Team in Canada in a CMAJ (Canadian Medical Association Journal) article. These models are useful tools for simulating plausible scenarios, developing control strategies and identifying important areas for immediate research.

The Pandemic Influenza Outbreak Research Modelling Team has helped characterize the epidemiology of the new H1N1 flu strain and advised on control strategies such as the use of antiviral drugs and school closures.

Mathematical models have shown that small seasonal variations in transmission of the influenza virus can drive large annual surges in the disease. Based on patterns of the 1918 influenza, models indicate that the H1N1 virus could become more severe in the fall. "Such models raise concern regarding the potential for the news S-OIV strain to cause serious epidemics in the near term in the southern hemisphere: South American countries, Australia and New Zealand will enter their upcoming influenza season without a vaccine against this strain," write Dr. David Fisman and coauthors.

The authors conclude that "making these models better understood and more accessible will provide a valuable additional weapon in the fight against emerging infectious diseases."

In a related article, Canada's first human-to-human transmission of the H1N1 influenza virus is presented in a research case study. The article looks at the cluster of cases in Nova Scotia in April 2009 and outlines transmission, diagnostic testing and public health measures to control the outbreak.


Story Source:

The above story is based on materials provided by Canadian Medical Association Journal. Note: Materials may be edited for content and length.


Cite This Page:

Canadian Medical Association Journal. "H1N1 Influenza Pandemic Modeling For Public Health Action." ScienceDaily. ScienceDaily, 21 July 2009. <www.sciencedaily.com/releases/2009/07/090720134227.htm>.
Canadian Medical Association Journal. (2009, July 21). H1N1 Influenza Pandemic Modeling For Public Health Action. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/07/090720134227.htm
Canadian Medical Association Journal. "H1N1 Influenza Pandemic Modeling For Public Health Action." ScienceDaily. www.sciencedaily.com/releases/2009/07/090720134227.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins